Need professional-grade analysis? Visit stockanalysis.com
$19.47M
N/A
4
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Israel China Biotechnology (ICB) Ltd (ICB) Price Performance
Israel China Biotechnology (ICB) Ltd (ICB) trades on TA in ILS. The company is classified in the Financials sector under the Investment Banking & Investment Services industry. The stock currently trades at ILS2495.00, up 1.84% from the previous close.
Over the past year, ICB has traded between a low of ILS214.10 and a high of ILS2500.00. The stock has gained 532.1% over this period. It is currently 1065.3% above its 52-week low.
Israel China Biotechnology (ICB) Ltd has a market capitalization of $19.47M.
About Israel China Biotechnology (ICB) Ltd
Silver Castle Holdings Ltd operates as a healthcare investment company. It invests in companies in the biomedical field in Israel. The company was formerly known as Israel China Biotechnology (ICB) Ltd and changed its name to Silver Castle Holdings Ltd in February 2022. Silver Castle Holdings Ltd was founded in 2000 and is based in Tel Aviv, Israel.
Company Info
- Sector
- Financials
- Exchange
- TA
- Currency
- ILS
- Country
- Israel
Financial Metrics
- Revenue (TTM)
- $-39,000
- EBITDA
- $-4,365,000
- Profit Margin
- -14375.90%
- EPS (TTM)
- -2.02
- Book Value
- 0.51
Technical Indicators
- 52 Week High
- ₪2,501.00
- 52 Week Low
- ₪101.00
- 50 Day MA
- ₪537.28
- 200 Day MA
- ₪760.95
- Beta
- 1.18
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 5.60
- Price/Book
- 6.89
- Enterprise Value
- $18.20M